Organ Transplant
12
2
3
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
25%
3 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Bone Microarchitecture in the Transplant Patient
Immune Registry for Organ Transplantation From COVID Positive Donors.
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors
ORCHARD- Optimising Home Assessment of Rural Patients
Trial to Compare the SherpaPak™ Device vs Cold Storage
Confirming Permanent Lack of Blood Flow to the Brain During A-NRP DCC Organ Transplant
PERTRIAL - Perla® Preservation Solution
Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail
Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Children Receiving Solid Organ Transplants
Wellness Interventions After Transplant Study